Large-scale Expansion and Exploitation of Pluripotent Stem Cells for Regenerative Medicine Purposes: Beyond the T Flask
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Human pluripotent stem cells will likely be a significant part of the regenerative medicine-driven healthcare revolution. In order to realize this potential, culture processes must be standardized, scalable and able to produce clinically relevant cell numbers, whilst maintaining critical biological functionality. This review comprises a broad overview of important bioprocess considerations, referencing the development of biopharmaceutical processes in an effort to learn from current best practice in the field. Particular focus is given to the recent efforts to grow human pluripotent stem cells in microcarrier or aggregate suspension culture, which would allow geometric expansion of productive capacity were it to be fully realized. The potential of these approaches is compared with automation of traditional T-flask culture, which may provide a cost-effective platform for low-dose, low-incidence conditions or autologous therapies. This represents the first step in defining the full extent of the challenges facing bioprocess engineers in the exploitation of large-scale human pluripotent stem cell manufacture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A ROCK inhibitor permits survival of dissociated human embryonic stem cells
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S.-I., Muguruma, K., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1310 · Cited by 2,055
Matrigel: A complex protein mixture required for optimal growth of cell culture
Hughes, C. S., Postovit, L. M., & Lajoie, G. A. (2010) · PROTEOMICS · doi:10.1002/pmic.200900758 · Cited by 1,534
Derivation of human embryonic stem cells in defined conditions
Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen, E. R., Frane, J. L., Crandall, L. J., Daigh, C. A., Conard, K. R., Piekarczyk, M. S., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1177 · Cited by 1,114
Reactor Engineering in Large Scale Animal Cell Culture
Nienow, A. W. (2006) · Cytotechnology · doi:10.1007/s10616-006-9005-8 · Cited by 433 · cited 2×
“This damage via the action of bursting bubbles can be easily eliminated by the addition of antifoaming agents such as Pluronic F68 to the culture medium (Nienow, 2006).”
BackgroundSelf-citationScalable Stirred-Suspension Bioreactor Culture of Human Pluripotent Stem Cells
Kehoe, D. E., Jing, D., Lock, L. T., & Tzanakakis, E. S. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0454 · Cited by 264
Teratomas from pluripotent stem cells: A clinical hurdle
Fong, C., Gauthaman, K., & Bongso, A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22775 · Cited by 222
CO2 in large-scale and high-density CHO cell perfusion culture
Gray, D. R., Chen, S., Howarth, W., Inlow, D., & Maiorella, B. L. (1996) · Cytotechnology · doi:10.1007/bf00353925 · Cited by 176
The scale−up of microbial batch and fed−batch fermentation processes
Hewitt, C. J., & Nienow, A. W. (2007) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(07)62005-x · Cited by 162
Self-citationStrategies for Improved dCO 2 Removal in Large‐Scale Fed‐Batch Cultures
Mostafa, S. S., & Gu, X. (. (2003) · Biotechnology Progress · doi:10.1021/bp0256263 · Cited by 113
Cited by
Spheroid culture as a tool for creating 3D complex tissues
Fennema, E., Rivron, N., Rouwkema, J., van Blitterswijk, C., & de Boer, J. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.003 · Cited by 1,054
Sun, W., Starly, B., Daly, A. C., Burdick, J. A., Groll, J., Skeldon, G., Shu, W., Sakai, Y., Shinohara, M., Nishikawa, M., et al. (2020) · Biofabrication · doi:10.1088/1758-5090/ab5158 · Cited by 426
Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor
Rafiq, Q. A., Brosnan, K. M., Coopman, K., Nienow, A. W., & Hewitt, C. J. (2013) · Biotechnology Letters · doi:10.1007/s10529-013-1211-9 · Cited by 212
“2 Introduction Regenerative medicine, of which cell-based therapies will play a significant role, has the potential to revolutionise the healthcare industry and replicate the success of the human therapeutic protein industry, which is currently valued at approximately UK£30 billion (Want et al. 2012).”
BackgroundMethodSelf-citationProgress and challenges in large-scale expansion of human pluripotent stem cells
Kropp, C., Massai, D., & Zweigerdt, R. (2017) · Process Biochemistry · doi:10.1016/j.procbio.2016.09.032 · Cited by 167
“In addition to simple Erlenmeyer flasks, these systems include wave bioreactors (also known as “cell bags”) and rotating wall, stirred tank, packed bed, hollow fiber, bubble column, and airlift bioreactors described in detail elsewhere [19,22,31,35,39,46–48] (Fig.”
In Vitro Strategies to Vascularize 3D Physiologically Relevant Models
Dellaquila, A., Le Bao, C., Letourneur, D., & Simon‐Yarza, T. (2021) · Advanced Science · doi:10.1002/advs.202100798 · Cited by 115
Metadata
- Authors
- Want, A. J., Nienow, A. W., Hewitt, C. J., & Coopman, K.
- Venue
- Regenerative Medicine
- Publisher
- Informa UK Limited
- Published
- 2011-12-15
- Volume
- 7
- Issue
- 1
- Pages
- 71-84
- ISSN
- 1746-0751 (ISSN-L)
- 1746-076X
- OpenAlex
- W2138965870
- Cited by
- 77
- References
- 9
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.